INGAPORE: The German drug giant Bayer Schering is in talks to expand its operations in Singapore. This is part of its efforts to grow in the region to keep up with demand.
Bayer Schering has already set aside S$20 million to work with local players to boost research and development in Singapore.
Chris Lee, the regional head of Bayer Schering Pharma Asia Pacific, said: "In addition to this already announced S$20 million investment in conjunction with the one at the leading university in Singapore in the area of cancer research, we do have an ongoing dialogue with many other institutions in Singapore.
"So we will be committed in investing more in Singapore and other Asian countries, and so these are ongoing negotiations in the developments."
Bayer Schering said sales increased by some 23 per cent on-year to S$1.9 billion in the Asia-Pacific region last year.
The company said growth is expected to continue at a double digit pace this year for its products such as Aspirin. Sales of Aspirin grew by some 55 per cent in 2008
Bayer Schering Pharma in talks to expand presence in Singapore
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment